3001 - 3025 of 8587 Results
Title
Year
-
OPENTitle: Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00400-0Best OA location URL: https://www.nature.com/articles/s41531-022-00400-0.pdfCitation Count: 15
- Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neurons2022OPENTitle: Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neuronsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00355-2Best OA location URL: https://www.nature.com/articles/s41531-022-00355-2.pdfCitation Count: 41
- Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy2022OPENTitle: Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00335-6Best OA location URL: https://www.nature.com/articles/s41531-022-00335-6.pdfCitation Count: 15
-
OPENTitle: Lipid level alteration in human and cellular models of alpha synuclein mutationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00313-yBest OA location URL: https://www.nature.com/articles/s41531-022-00313-y.pdfCitation Count: 14
-
OPENTitle: Dancing Feet Dyskinesia in a Patient with GBA-PDJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 15Issue #: 1Start Page: 83End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20169Best OA location URL: http://e-jmd.org/upload/jmd-20169.pdfCitation Count: 0
-
OPENTitle: The Regulation of ImmunityJournal Name: The Journal of ImmunologyPublisher: Oxford University Press (OUP)Vol: 208Issue #: 11Start Page: 2450End Page: 2455Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.2290007Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/208/11/2450/1501657/ji2290007.pdfCitation Count: 0
- Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert Panel2022OPENTitle: Screening, Diagnosis, and Management of Parkinson’s Disease Psychosis: Recommendations From an Expert PanelJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 4Start Page: 1571End Page: 1582Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00388-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00388-y.pdfCitation Count: 7
-
OPENTitle: Resilience and Trauma among Patients with Parkinson’s Disease during the COVID-19 PandemicJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 15Issue #: 1Start Page: 77End Page: 79Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20126Best OA location URL: http://e-jmd.org/upload/jmd-20126.pdfCitation Count: 3
- Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc Analyses2022OPENTitle: Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc AnalysesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 2Start Page: 711End Page: 723Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00332-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00332-0.pdfCitation Count: 1
- Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment2022OPENTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 5
- Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries2022OPENTitle: Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 CountriesJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 303End Page: 318Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00313-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00313-9.pdfCitation Count: 11
- Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON Trial2022OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 7
-
OPENTitle: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein ToxicityJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 1018End Page: 1036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-022-01199-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-022-01199-7.pdfCitation Count: 14
- Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetJournal Name: Pharmacological ReportsPublisher: Springer Science and Business Media LLCVol: 74Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43440-022-00378-9Citation Count: 5
- The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England2022OPENTitle: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in EnglandJournal Name: PharmacoEconomicsPublisher: Springer Science and Business Media LLCVol: 40Issue #: 5Start Page: 559End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40273-022-01132-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40273-022-01132-y.pdfCitation Count: 10
- An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol2022OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 11
-
OPENTitle: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stressJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-20261-0Best OA location URL: https://www.nature.com/articles/s41598-022-20261-0.pdfCitation Count: 20
-
OPENTitle: Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synucleinJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-07706-2Best OA location URL: https://www.nature.com/articles/s41598-022-07706-2.pdfCitation Count: 13
- Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal Study2022OPENTitle: Magnetic Resonance T1w/T2w Ratio in the Putamen and Cerebellum as a Marker of Cognitive Impairment in MSA: a Longitudinal StudyJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 810End Page: 817Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12311-022-01455-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12311-022-01455-8.pdfCitation Count: 7
- Does Head Tremor Predict Postural Instability After Bilateral Thalamic Stimulation in Essential Tremor?2022RESTRICTEDTitle: Does Head Tremor Predict Postural Instability After Bilateral Thalamic Stimulation in Essential Tremor?Journal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 22Issue #: 5Start Page: 1039End Page: 1044Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-022-01477-2Citation Count: 3
-
OPENTitle: Leveraging Patient Preference Information in Medical Device Clinical Trial DesignJournal Name: Therapeutic Innovation & Regulatory SciencePublisher: Springer Science and Business Media LLCVol: 57Issue #: 1Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s43441-022-00450-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s43441-022-00450-9.pdfCitation Count: 7
- Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variants2022OPENTitle: Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer’s disease-associated genetic variantsJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41398-022-01913-1Best OA location URL: https://www.nature.com/articles/s41398-022-01913-1.pdfCitation Count: 17
- Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor function2022OPENTitle: Virtual exam for Parkinson’s disease enables frequent and reliable remote measurements of motor functionJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00607-8Best OA location URL: https://www.nature.com/articles/s41746-022-00607-8.pdfCitation Count: 63
-
OPENTitle: Shared mechanisms across the major psychiatric and neurodegenerative diseasesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31873-5Best OA location URL: https://escholarship.org/content/qt23t9767x/qt23t9767x.pdfCitation Count: 125
- Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks2022OPENTitle: Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networksJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-022-00674-xBest OA location URL: https://www.nature.com/articles/s41746-022-00674-x.pdfCitation Count: 26